Covering the following topics: early recognition in asymptomatic patients to interventions in high risk patients, and cover the expanding spectrum of drugs and devices designed to diagnose, monitor, treat and detect evidence of worsening
Panama City, Panama (PRWEB) June 21, 2012
The Pan American Congress on Heart Failure (PAHF) to be held at the El Panama Hotel, in Panama City, Panama from October 18-21, is the preeminent meeting for cardiologists, internists, nephrologists, primary care physicians and those practicing in other relevant cardiovascular fields.
The PAHF congress will provide the forum for focusing on how to best prevent and treat heart failure (HF) of various etiologists.
With cardiovascular disorders being the pre-eminent cause of morbidity, mortality, and hospitalization in many developed countries around the world, the PAHF congress will provide the opportunity for world renowned experts to lecture, present case studies, and participate in panel discussions about this all too common condition.
The aging of the world’s population and the increase in risk factors associated with congestive heart failure (CHF) - the frequent end stage of cardiac disease and a major chronic condition and the most common cardiovascular cause of hospitalizations - are imposing enormous costs on the health system and causing much grief and suffering to those afflicted by the condition and their families. With between 6-10% of those over age 65 suffering from HF, this condition is cause for much consternation not only for sufferers and the medical profession.
The depth and breadth of this debilitating disease will be covered in lectures that will be simultaneously translated to English and Spanish and comprise the following topics: early recognition in asymptomatic patients to interventions in high risk patients, and cover the expanding spectrum of drugs and devices designed to diagnose, monitor, treat and detect evidence of worsening.
The curriculum includes updates on the diagnostic and therapeutic approach to the management of patients with acute decompensated HF, systolic and diastolic HF, HF due to coronary disease, cardiomyopathies and valvular heart disease, sudden death, genetics, cardiovascular physiology, molecular biology, pharmacologic therapy surgery (transplantation, devices), neurohormones and tissue factors, electrophysiology and arrhythmias, atrial fibrillation, biomarkers and devices to aid in diagnosis, expanding indications for implantable defibrillators and cardiac resynchronization therapy, as well as treatment of pulmonary hypertension, sleep apnea and stem cell therapy.
The PAHF congress will be chaired this year by the esteemed Dr. Uri Elkayam, MD, Professor of Medicine at the University of Southern California, Los Angeles, and past member of the Executive Council and Practice Guidelines committee of the Heart Failure Society of America.
The congress will take place in beautiful Panama City, the capital and largest city of the Republic of Panama and the political and administrative center of Panama. Flanked on the south by the Pacific Ocean and on the north by the Caribbean Sea, Panama is a fisherman’s paradise. Panama actually means “abundance of fish.”
With over 1,500 islands and 480 rivers, Panama boasts abundant natural gifts including magnificent beaches and luscious vegetation. As well as a rich history, the Panama Canal is one the great man-made wonders.
About the PAHF Congress: The Pan American Congress on Heart Failure, to be held at the El Panama Hotel, in Panama City, Panama from October 18-21 will provide the forum for an in-depth focus on the best approaches for preventing and treating heart failure (HF). The conference will be chaired by the esteemed Dr. Uri Elkayam, MD, Professor of Medicine at the University of Southern California, Los Angeles.